Clinical Trial

BIA-Guided vs. Conventional Fluid Resuscitation in ICU Patients

Study acronym: BIA-FLUID
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 8, 2025 (before its estimated August 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
In this study aimed to compare bioelectrical impedance analysis (BIA)-guided fluid resuscitation with conventional fluid management strategies in patients admitted to the intensive care unit (ICU) following major surgery. The primary objective is to evaluate whether BIA-guided fluid therapy reduces 28-day mortality by optimizing fluid balance and preventing volume-related complications. Secondary outcomes include cumulative fluid balance, ICU and hospital length of stay, duration of mechanical ventilation, and need for vasopressor or inotropic support. This study is expected to provide evidence for the clinical utility and applicability of BIA in guiding postoperative fluid therapy in critically ill patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-25.
Trial Details
NCT Number NCT07142083
Lead Sponsor Ondokuz Mayıs University
Conditions Fluid and Electrolyte Imbalance, Anesthesia
Enrollment 80 participants
Start Date 2025-09-15
Primary Completion 2026-08-15 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-08